New and evolving concepts in the neurotoxicology of lead

Neuroscience

• Chaperone 100%
• Neurotoxicology 100%
• Glucocorticoid 66%
• Astrocyte 66%
• Hippocampus 66%
• Alzheimer's Disease 66%
• Neurogenesis 66%
• Cognitive Disorders 66%
• Interleukin 6 66%
• Synaptic Plasticity 66%
• Nervous System 66%
• In Vitro 33%
• Amyloid Precursor Protein 33%
• Neurodegeneration 33%
• Learning Disabilities 33%
• Adverse Effect 33%
• Beta Amyloid 33%
• Long-Term Potentiation 33%
• Glutamic Acid 33%
• NMDA Receptor 33%
• Cell Growth 33%
• Glucose Regulated Protein 33%
• Glucose Regulated Protein 78 33%
• Cell Specificity 33%
• Dopamine 33%
• Cytokine 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Chaperone 100%
• Neurotoxicology 100%
• Glucocorticoid 66%
• Alzheimer's Disease 66%
• Cognitive Defect 66%
• Interleukin 6 66%
• Diseases 66%
• Cytokine 33%
• Adverse Event 33%
• Nerve Degeneration 33%
• Glutamic Acid 33%
• Amyloid Precursor Protein 33%
• Glucose Regulated Protein 33%
• Glucose Regulated Protein 78 33%
• Learning Disorder 33%
• N Methyl Dextro Aspartic Acid Receptor 33%
• Amyloid Protein 33%
• Lead Poisoning 33%
• Dopamine 33%
• Toxicology 33%

Keyphrases

• Evolving Concepts 100%
• Protein Amyloid 25%